Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients
Clinical trial NCT06252584 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06252584
- Sponsor
- University Hospital Tuebingen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2026-05-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.